ID

28935

Description

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3); ODM derived from: https://clinicaltrials.gov/show/NCT00642174

Lien

https://clinicaltrials.gov/show/NCT00642174

Mots-clés

Versions (1)
  1. 18/02/2018 18/02/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

18 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus NCT00642174

Anglais

Eligibility Diabetes Mellitus NCT00642174

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus and on oral or parenteral hypoglycemic therapy for at least 1 month.
Description

Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT | Hypoglycemic Agents Parenteral

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0747045
UMLS CUI [3,1]
C0020616
UMLS CUI [3,2]
C1518896
history of coronary artery disease with or without other types of vascular disease (such as peripheral vascular disease).
Description

Coronary Artery Disease | Vascular Diseases | Vascular Diseases Absent | Peripheral Vascular Diseases | Peripheral Vascular Diseases Absent

Type de données

boolean

Alias
UMLS CUI [1]
C1956346
UMLS CUI [2]
C0042373
UMLS CUI [3,1]
C0042373
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0085096
UMLS CUI [5,1]
C0085096
UMLS CUI [5,2]
C0332197
taking aspirin 75-325 mg/day for at least 1 week prior to randomization.
Description

Aspirin U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
between the ages of 18-74 years old.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
if a woman of child bearing age, must not be pregnant and must agree to use reliable method of birth control during the duration of the study.
Description

Childbearing Potential Pregnancy Absent | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0032961
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
thienopyridine therapy within 30 days or have a defined need for thienopyridine treatment.
Description

thienopyridine | Patient need for thienopyridine

Type de données

boolean

Alias
UMLS CUI [1]
C1120149
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C1120149
coronary artery bypass graft (cabg) or percutaneous coronary intervention (pci) with no stent placed within 30 days.
Description

Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Placement of stent Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0010055
UMLS CUI [2]
C1532338
UMLS CUI [3,1]
C0522776
UMLS CUI [3,2]
C0332197
planned coronary revascularization
Description

Coronary revascularisation Planned

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877341
UMLS CUI [1,2]
C1301732
hemoglobin a1c (hba1c) > or equal to 10 mg/dl within the last 3 months.
Description

Glucohemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
received fibrolytic therapy <24 hours prior to randomization.
Description

Fibrinolytic Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0040044
received non-fibrin-specific fibrinolytic therapy <48 hours prior to randomization.
Description

Fibrinolytic Therapy | Fibrin Specific Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0040044
UMLS CUI [2,1]
C0015982
UMLS CUI [2,2]
C0205369
UMLS CUI [2,3]
C0332197
at risk of bleeding.
Description

Bleeding Risk

Type de données

boolean

Alias
UMLS CUI [1]
C3251812
history of ischemic stroke, transient ischemic attack (tia), intercranial neoplasm, arteriovenous malformation, or aneurysm.
Description

Ischemic stroke | Transient Ischemic Attack | Neoplasms, Intracranial | Arteriovenous malformation | Aneurysm

Type de données

boolean

Alias
UMLS CUI [1]
C0948008
UMLS CUI [2]
C0007787
UMLS CUI [3]
C1527390
UMLS CUI [4]
C0003857
UMLS CUI [5]
C0002940
body weight <60 kilograms (kg).
Description

Body Weight

Type de données

boolean

Alias
UMLS CUI [1]
C0005910
international normalized ratio (inr) >1.5, platelet count <100,000/mm3, or anemia (hemoglobin <10 gm/dl) within 1 week of study entry.
Description

International Normalized Ratio | Platelet Count measurement | Anemia | Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0002871
UMLS CUI [4]
C0518015
are receiving or will receive oral anticoagulation or antiplatelet treatment therapy.
Description

Anticoagulation Therapy Oral | Antiplatelet therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C1096021
are being treated with daily non-steroidal anti-inflammatory drugs (nsaids).
Description

Anti-Inflammatory Agents, Non-Steroidal

Type de données

boolean

Alias
UMLS CUI [1]
C0003211
are pregnant, breast-feeding or plan to become pregnant.
Description

Pregnancy | Breast Feeding | Pregnancy, Planned

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
Retour au début de la page

Similar models

Eligibility Diabetes Mellitus NCT00642174

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT | Hypoglycemic Agents Parenteral
Item
type 2 diabetes mellitus and on oral or parenteral hypoglycemic therapy for at least 1 month.
boolean
C0011860 (UMLS CUI [1])
C0747045 (UMLS CUI [2])
C0020616 (UMLS CUI [3,1])
C1518896 (UMLS CUI [3,2])
Coronary Artery Disease | Vascular Diseases | Vascular Diseases Absent | Peripheral Vascular Diseases | Peripheral Vascular Diseases Absent
Item
history of coronary artery disease with or without other types of vascular disease (such as peripheral vascular disease).
boolean
C1956346 (UMLS CUI [1])
C0042373 (UMLS CUI [2])
C0042373 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0085096 (UMLS CUI [4])
C0085096 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Aspirin U/day
Item
taking aspirin 75-325 mg/day for at least 1 week prior to randomization.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Age
Item
between the ages of 18-74 years old.
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Pregnancy Absent | Childbearing Potential Contraceptive methods
Item
if a woman of child bearing age, must not be pregnant and must agree to use reliable method of birth control during the duration of the study.
boolean
C3831118 (UMLS CUI [1,1])
C0032961 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
thienopyridine | Patient need for thienopyridine
Item
thienopyridine therapy within 30 days or have a defined need for thienopyridine treatment.
boolean
C1120149 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C1120149 (UMLS CUI [2,2])
Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Placement of stent Absent
Item
coronary artery bypass graft (cabg) or percutaneous coronary intervention (pci) with no stent placed within 30 days.
boolean
C0010055 (UMLS CUI [1])
C1532338 (UMLS CUI [2])
C0522776 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Coronary revascularisation Planned
Item
planned coronary revascularization
boolean
C0877341 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hemoglobin a1c (hba1c) > or equal to 10 mg/dl within the last 3 months.
boolean
C0202054 (UMLS CUI [1])
Fibrinolytic Therapy
Item
received fibrolytic therapy <24 hours prior to randomization.
boolean
C0040044 (UMLS CUI [1])
Fibrinolytic Therapy | Fibrin Specific Absent
Item
received non-fibrin-specific fibrinolytic therapy <48 hours prior to randomization.
boolean
C0040044 (UMLS CUI [1])
C0015982 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Bleeding Risk
Item
at risk of bleeding.
boolean
C3251812 (UMLS CUI [1])
Ischemic stroke | Transient Ischemic Attack | Neoplasms, Intracranial | Arteriovenous malformation | Aneurysm
Item
history of ischemic stroke, transient ischemic attack (tia), intercranial neoplasm, arteriovenous malformation, or aneurysm.
boolean
C0948008 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
C1527390 (UMLS CUI [3])
C0003857 (UMLS CUI [4])
C0002940 (UMLS CUI [5])
Body Weight
Item
body weight <60 kilograms (kg).
boolean
C0005910 (UMLS CUI [1])
International Normalized Ratio | Platelet Count measurement | Anemia | Hemoglobin measurement
Item
international normalized ratio (inr) >1.5, platelet count <100,000/mm3, or anemia (hemoglobin <10 gm/dl) within 1 week of study entry.
boolean
C0525032 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Anticoagulation Therapy Oral | Antiplatelet therapy
Item
are receiving or will receive oral anticoagulation or antiplatelet treatment therapy.
boolean
C0003281 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1096021 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal
Item
are being treated with daily non-steroidal anti-inflammatory drugs (nsaids).
boolean
C0003211 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
are pregnant, breast-feeding or plan to become pregnant.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial